NuVision Pharmacy, Inc.

Form 483 issued October 9, 2015 · Dallas, Texas

Inspection
Sep 14 – Oct 9, 2015
Observations
14
Pages
14
FEI number
3010087152

In short: On October 9, 2015, FDA issued a Form 483 with 14 observations to NuVision Pharmacy, Inc. in Dallas, Texas (FEI 3010087152) after an inspection that ran Sep 14 – Oct 9, 2015. The investigators were Jeffrey D. Meng, Jenny Agila Sefen and Patrice S. Hall. Most observations concern quality system and production.

At a glance

Quality system and production account for 2 of 3 observations.

Quality system1
Production1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure ofa batdt or…

  2. 02

    Procedures designed to prevent microbiological contamination ofdJug products purporting to be sterile do not include adequate…

  3. 03

    Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment…

11 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at NuVision Pharmacy, Inc.?

FDA listed 14 observations on this Form 483, mostly about quality system, production and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected NuVision Pharmacy, Inc.?

Jeffrey D. Meng, Jenny Agila Sefen and Patrice S. Hall are named on this Form 483, for the inspection of Sep 14 – Oct 9, 2015. Each investigator has a profile showing what they cite most.

When was NuVision Pharmacy, Inc. inspected by FDA?

The inspection ran Sep 14 – Oct 9, 2015, and the Form 483 is dated October 9, 2015.

How do I get the full Form 483 for NuVision Pharmacy, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free